News | September 22, 2023
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The market capitalization of the company stood at Rs. 7,000 crore +
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Patient Advisory Councils (PACs) to be set up across hospitals to make patients true partners in enhancing patient safety and improving care delivery
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Subscribe To Our Newsletter & Stay Updated
